FdaApplication
NDA 017521
Identifiers
- fda_app_no: NDA017521
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 1982-03-26 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXTROSE 20% IN PLASTIC CONTAINER | DEXTROSE | 20GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DEXTROSE 30% IN PLASTIC CONTAINER | DEXTROSE | 30GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DEXTROSE 40% IN PLASTIC CONTAINER | DEXTROSE | 40GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DEXTROSE 50% IN PLASTIC CONTAINER | DEXTROSE | 50GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DEXTROSE 60% IN PLASTIC CONTAINER | DEXTROSE | 60GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| DEXTROSE 70% IN PLASTIC CONTAINER | DEXTROSE | 70GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
6 products